KAYLA BOND: Open Payments
NPI 1255912705 · SEARCY, AR. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$353 in 20 payments from 7 companies in 2025. Trend: 2023 $957 · 2024 $588 · 2025 $353
Food & beverage: $353
| Company | Payments | Amount |
|---|---|---|
| Merck Sharp & Dohme LLC | 8 | $135 |
| Novartis Pharmaceuticals Corporation | 6 | $103 |
| PFIZER INC. | 2 | $38 |
| Tarsus Pharmaceuticals, Inc. | 1 | $25 |
| Boston Scientific Corporation | 1 | $18 |
| Actelion Pharmaceuticals US, Inc. | 1 | $18 |
| Philips North America LLC | 1 | $17 |
Products named: VERQUVO, LEQVIO, VYNDAQEL, CAPVAXIVE, XDEMVY, WATCHMAN FLX, UPTRAVI, Extended Holter.
Industry payments across AR — which companies pay providers there.
